Cargando…
Primary pulmonary lymphoma in Peru
OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enferm...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310327/ https://www.ncbi.nlm.nih.gov/pubmed/37396099 http://dx.doi.org/10.3332/ecancer.2023.1559 |
Sumario: | OBJECTIVE: To describe the clinical features, imaging, pathology and management of patients with primary pulmonary lymphoma (PPL). METHODOLOGY: This is a case series study involving a retrospective analysis of 24 patients diagnosed with PPL between the years 2000–2019 at Instituto Nacional de Enfermedades Neoplásicas in Lima, Perú. RESULTS: 73.9% of patients were male. Cough (78.3%) and weight loss (56.5%) were the most frequent clinical features. Dyspnoea and elevated values of DHL and B2 microglobulin were frequently altered in advanced stages. Diffuse large B cell lymphoma (DLBCL) represented 47.8% of the cases and the most common radiologic alterations were a mass (60%) and consolidation with air bronchogram (60%). The most utilised treatment was chemotherapy alone (60%). Three patients received only surgery. Median survival was 30 months. Five overall survival was 45%, and up to 60% in the case of mucosa-associated lymphoid tissue lymphoma. CONCLUSION: PPL is infrequent. Clinical features are unspecific and the principal finding is a mass, nodule or consolidation with air bronchogram. Definitive diagnosis needs biopsy and immunohistochemistry. There is no standard treatment, it depends on histology type and stage. |
---|